Research Is First to Pinpoint a Gut Organism to Lupus, Advancing Understanding of the Microbiome in Autoimmune Disease NEW YORK, NY. June 9, 2021. The Lupus Research Alliance (LRA) announced today that Martin Kriegel, MD, PhD, of the University of Münster is the 2021 Lupus Insight Prize Awardee for his cutting edge research in the […] READ MORE
June 2, 2021 The Lupus Research Alliance’s strong financial health and commitment to accountability and transparency have earned it the coveted 4-star rating – the highest given – from Charity Navigator, America’s largest independent evaluator of U.S. charities. The Lupus Research Alliance has earned this top distinction every year since it was founded in 2016. […] READ MORE
June 1, 2021 As Lupus Awareness Month 2021 has come to a close, LRA President Ken Farber takes a look at the many ways we came together to Lift Up Lupus. Take pride in all the lupus community accomplished and hope in the tremendous progress underway. WATCH HERE As Ken touched on, here are some […] READ MORE
May 27, 2021 Funding innovative research year-round is the most meaningful way the Lupus Research Alliance Lifts Up Lupus with the promise of better treatments and one day a cure. This excellent article in EVERYDAY HEALTH reports on eight of the most important discoveries in lupus of the past year, virtually all of which got […] READ MORE
May 26, 2021 Memorial Day weekend is unofficially the beginning of summer, and this year, a particularly welcome opportunity to get outside with family or friends. Since several vaccines for COVID-19 were released, the U.S. Centers for Disease Control has started allowing travel and socializing again with specific guidelines. But as the beautiful weather calls […] READ MORE
May 14, 2021 The Lupus Research Alliance (LRA) is proud to share that one of our grantees Katherine A. Fitzgerald, PhD was elected into the National Academy of Sciences. Dr. Fitzgerald is recognized for her distinguished, original and continuing research in deciphering the molecular mechanisms of inflammatory processes that underpin a number of diseases including […] READ MORE
May 13, 2021 A new study analyzing data from two large clinical trials showed that the investigational therapy anifrolumab reduced flares in people with moderate to severe lupus while allowing lowered steroid use. The study was published in the professional journal Lupus by top lupus researchers, several of whom are leaders in the Lupus Clinical […] READ MORE
May 12, 2021 In celebration of International Nurses Day, the LRA brings you the inspiring story of Dr. Bridget A. Leonard, DNP, RN, MBA, HCM, CRRN, NEA-BC, a nurse who had to learn to care for herself and her daughter with lupus. International Nurses Day is celebrated May 12, the birthday of one of the […] READ MORE
May 11, 2021 A new study published in Arthritis & Rheumatology by researchers at Harvard University and Brigham and Women’s Hospital showed low rates of vaccinations among people with lupus covered by Medicaid for illnesses like flu, pneumonia, herpes that could be prevented with vaccines. Of 45,654 Medicaid beneficiaries with SLE, less than 10% had […] READ MORE
May 11, 2021 The Lupus Research Alliance is pleased to share the following article by one of our grantees Dr. Andrea Knight on hopeful developments in neuropsychiatric lupus and how her own research is improving mental health among children with lupus. Supporting major research advances is how the LRA fulfills its mission to Lift Up […] READ MORE
May 10, 2021 The highly prestigious medical journal The Lancet published the results of Aurinia’s Phase 3 AURORA 1 study testing Lupkynis™ (voclosporin) in adults with lupus nephritis. Lupkynis was approved by the U.S. Food and Drug Administration based on these data. The AURORA 1 study results showed that Lupkynis in combination with the commonly used […] READ MORE
With lupus, the immune system attacks instead of protects the body, including the brain and nervous system. Lupus and its treatments can impair mental & emotional health. Neuropsychiatric lupus affects 80-90% of people with lupus. Neuropsychiatric lupus describes feelings of depression, headaches, and lupus fog — trouble thinking or remembering due […] READ MORE
